NCT04071756 2024-02-07
Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions
Dana-Farber Cancer Institute
Phase 2 Terminated
Clinical Trials
5 trialsNCT00489086 2020-10-29
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face
UCSF Benioff Children's Hospital Oakland
Phase 2 Completed
NCT00783965 2016-02-11
Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
UCSF Benioff Children's Hospital Oakland
Phase 2 Completed
NCT01053000 2015-08-11
Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses
Stewart, Roger H., M.D., P.A.
Phase NA Completed
NCT00779896 2008-10-24
Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study
McGill University
Phase 1/2 Unknown